Status | Study |
Completed |
Study Name: Arikayce for Nontuberculous Mycobacteria Condition: Mycobacterium Infections, Nontuberculous Date: 2011-03-11 Interventions: Drug: Liposomal amikacin for inhalation (LAI) |
Recruiting |
Study Name: Treatment of Mycobacterium Xenopi Pulmonary Infection Condition: Atypical; Mycobacterium, Pulmonary, Tuberculous Date: 2011-02-15 Interventions: Drug: Clarithromycin 500 mg tw |
Completed |
Study Name: Special Investigation of Clarith/Klaricid in Patients With Non-tuberculous Mycobacterial Pulmonary Infections Condition: Mycobacterium Infections, Atypical Date: 2010-02-26 |
Completed |
Study Name: Mycobacterium Avium Intracellulare Complex (MAC) Study Condition: Mycobacterium Avium Intracellulare Complex (MAC) Date: 2009-01-20 |
Completed |
Study Name: Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis Condition: Rate of Exit Site Infection Rate of Atypical Mycobacterial Infection Date: 2008-09-10 Interventions: Drug: gentamicin topical genta |
Completed |
Study Name: Clofazamine for the Treatment of Mycobacterium Avium Intracellulare(MAI) Condition: Infection, Mycobacterium Avium-Intracellulare Date: 2008-03-31 |
Completed |
Study Name: Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM) Condition: Nontuberculous Mycobacteria Mycobacterium Avium Complex Date: 2008-01-14 Interventions: Drug: Clarithromycin Dosage dependent on clinical factors such as age, weight and patient-specific healt |
Completed |
Study Name: Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection Condition: Mycobacterium Avium-Intracellulare Infection Date: 2005-05-19 Interventions: Procedure: Cytokine therapy Drug: Interfer |
Terminated |
Study Name: Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection Condition: Lung Infection Date: 2002-08-07 Interventions: Drug: interferon gamma-1b 500 mcg, oral, three times weekly |
Completed |
Study Name: A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections Condition: Mycobacterium Avium-Intracellulare Infection Date: 2001-07-24 Interventions: Drug: Interferon Gamma for Aerosol |